Promising Agents Could Alter the Treatment Paradigm in Metastatic TNBC

Joyce A. O’Shaughnessy, MD Since triple-negative breast cancer (TNBC) is resistant to multiple therapies, physicians have little flexibility for treatment options. However, anticipation is building for potential alternatives. “Right now, for TNBC, chemotherapy is our only option,” said Joyce A. O’Shaughnessy, MD, co-chair of Breast Cancer Research and the […]

Leave a Reply